Cargando…
Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395384/ http://dx.doi.org/10.1186/1897-4287-10-S2-A11 |
| _version_ | 1782237976307171328 |
|---|---|
| author | Phillips, KA Milne, RL Rookus, MA Goldgar, D Friedlander, M McLachlan, SA Buys, S Antoniou, AC Birch, K Terry, MB Easton, DF Weideman, P Daly, M Andrieu, N John, EM Hooning, MJ Andrulis, IL Caldes, T Olsson, H Hopper, JL |
| author_facet | Phillips, KA Milne, RL Rookus, MA Goldgar, D Friedlander, M McLachlan, SA Buys, S Antoniou, AC Birch, K Terry, MB Easton, DF Weideman, P Daly, M Andrieu, N John, EM Hooning, MJ Andrulis, IL Caldes, T Olsson, H Hopper, JL |
| author_sort | Phillips, KA |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3395384 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-33953842012-07-16 Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers Phillips, KA Milne, RL Rookus, MA Goldgar, D Friedlander, M McLachlan, SA Buys, S Antoniou, AC Birch, K Terry, MB Easton, DF Weideman, P Daly, M Andrieu, N John, EM Hooning, MJ Andrulis, IL Caldes, T Olsson, H Hopper, JL Hered Cancer Clin Pract Meeting Abstract BioMed Central 2012-04-12 /pmc/articles/PMC3395384/ http://dx.doi.org/10.1186/1897-4287-10-S2-A11 Text en Copyright ©2012 Phillips et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Meeting Abstract Phillips, KA Milne, RL Rookus, MA Goldgar, D Friedlander, M McLachlan, SA Buys, S Antoniou, AC Birch, K Terry, MB Easton, DF Weideman, P Daly, M Andrieu, N John, EM Hooning, MJ Andrulis, IL Caldes, T Olsson, H Hopper, JL Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers |
| title | Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers |
| title_full | Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers |
| title_fullStr | Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers |
| title_full_unstemmed | Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers |
| title_short | Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers |
| title_sort | association of tamoxifen use and reduced risk of contralateral breast cancer for brca1 and brca2 mutation carriers |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395384/ http://dx.doi.org/10.1186/1897-4287-10-S2-A11 |
| work_keys_str_mv | AT phillipska associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT milnerl associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT rookusma associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT goldgard associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT friedlanderm associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT mclachlansa associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT buyss associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT antoniouac associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT birchk associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT terrymb associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT eastondf associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT weidemanp associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT dalym associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT andrieun associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT johnem associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT hooningmj associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT andrulisil associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT caldest associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT olssonh associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers AT hopperjl associationoftamoxifenuseandreducedriskofcontralateralbreastcancerforbrca1andbrca2mutationcarriers |